Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice

Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial

(2014) Karen Hambardzumyan et al.   ANNALS OF THE RHEUMATIC DISEASES

Comprehensive disease control (CDC): what does achieving CDC mean for patients with rheumatoid arthritis?

(2014) Paul Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

A Multibiomarker Disease Activity Score for Rheumatoid Arthritis Predicts Radiographic Joint Damage in the BeSt Study

(2014) I. M. Markusse et al.   JOURNAL OF RHEUMATOLOGY

A multi-biomarker disease activity score tracks clinical response consistently in patients with rheumatoid arthritis treated with different anti-tumor necrosis factor therapies: A retrospective observational study

(2014) Shintaro Hirata et al.   Modern Rheumatology

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

(2013) Josef S Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Longterm Effect of Delaying Combination Therapy with Tumor Necrosis Factor Inhibitor in Patients with Aggressive Early Rheumatoid Arthritis: 10-year Efficacy and Safety of Adalimumab from the Randomized Controlled PREMIER Trial with Open-label Extension

(2013) E. C. Keystone et al.   JOURNAL OF RHEUMATOLOGY

Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis

(2013) Michael Centola et al.   PLoS One

An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression

(2013) Annette H. M. van der Helm-van Mil et al.   RHEUMATOLOGY

A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study

(2013) Shintaro Hirata et al.   RHEUMATOLOGY

Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study

(2012) Marije F Bakker et al.   ANNALS OF THE RHEUMATIC DISEASES

Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis

(2012) Yoshiya Tanaka   CURRENT OPINION IN RHEUMATOLOGY

Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis

(2012) P. Scott Eastman et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity

(2012) Jeffrey R. Curtis et al.   ARTHRITIS CARE & RESEARCH

Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort

(2011) Siri Lillegraven et al.   ANNALS OF THE RHEUMATIC DISEASES

The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review

(2011) Claire Bombardier et al.   ANNALS OF THE RHEUMATIC DISEASES

Treating rheumatoid arthritis to target: recommendations of an international task force

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Less Radiographic Progression with Adalimumab Plus Methotrexate Versus Methotrexate Monotherapy Across the Spectrum of Clinical Response in Early Rheumatoid Arthritis

(2009) P. EMERY et al.   JOURNAL OF RHEUMATOLOGY

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis

(2009) Peter C. Taylor et al.   Nature Reviews Rheumatology

The Disease Activity Score and the EULAR Response Criteria

(2009) Jaap Fransen et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade

(2008) J S Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES